Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Improving attribution of adverse events in oncology clinical trials.

George GC, Barata PC, Campbell A, Chen A, Cortes JE, Hyman DM, Jones L, Karagiannis T, Klaar S, Le-Rademacher JG, LoRusso P, Mandrekar SJ, Merino DM, Minasian LM, Mitchell SA, Montez S, O'Connor DJ, Pettit S, Silk E, Sloan JA, Stewart M, Takimoto CH, Wong GY, Yap TA, Cleeland CS, Hong DS.

Cancer Treat Rev. 2019 Jun;76:33-40. doi: 10.1016/j.ctrv.2019.04.004. Epub 2019 Apr 25. Review.

PMID:
31108240
2.

Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.

George GC, Iwuanyanwu EC, Buford AS, Piha-Paul SA, Subbiah V, Fu S, Karp DD, Pant S, Hinojosa CO, Hess KR, Cleeland CS, Bernstam EV, Meric-Bernstam F, Hong DS.

J Med Internet Res. 2019 Mar 14;21(3):e10348. doi: 10.2196/10348.

3.

Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.

Fu C, Gombos DS, Lee J, George GC, Hess K, Whyte A, Hong DS.

Oncotarget. 2019 Jan 29;10(9):1011-1013. doi: 10.18632/oncotarget.26658. eCollection 2019 Jan 29.

4.

Cancer-Related Internet Use and Online Social Networking Among Patients in an Early-Phase Clinical Trials Clinic at a Comprehensive Cancer Center.

George GC, Buford A, Hess K, Piha-Paul SA, Zinner R, Subbiah V, Hinojosa C, Cleeland CS, Meric-Bernstam F, Bernstam EV, Hong DS.

JCO Clin Cancer Inform. 2018 Dec;2:1-14. doi: 10.1200/CCI.17.00030.

5.

Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.

Fu C, Gombos DS, Lee J, George GC, Hess K, Whyte A, Hong DS.

Oncotarget. 2017 May 5;8(35):58709-58727. doi: 10.18632/oncotarget.17634. eCollection 2017 Aug 29. Erratum in: Oncotarget. 2019 Jan 29;10(9):1011-1013.

6.

Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.

Kehl KL, Fullmer CP, Fu S, George GC, Hess KR, Janku F, Karp DD, Kato S, Kizer CK, Kurzrock R, Naing A, Pant S, Piha-Paul SA, Subbiah V, Tsimberidou AM, Hong DS.

Clin Cancer Res. 2017 Jul 20. doi: 10.1158/1078-0432.CCR-16-3027. [Epub ahead of print]

7.

Relative Validity and Reliability of a 1-Week, Semiquantitative Food Frequency Questionnaire for Women Participating in the Supplemental Nutrition Assistance Program.

Sanjeevi N, Freeland-Graves J, George GC.

J Acad Nutr Diet. 2017 Dec;117(12):1972-1982.e2. doi: 10.1016/j.jand.2017.05.013. Epub 2017 Jun 29.

PMID:
28669810
8.

Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.

George GC, Iwuanyanwu EC, Anderson KO, Yusuf A, Zinner RG, Piha-Paul SA, Tsimberidou AM, Naing A, Fu S, Janku F, Subbiah V, Cleeland CS, Mendoza TR, Hong DS.

Cancer. 2016 Nov 15;122(21):3401-3409. doi: 10.1002/cncr.30182. Epub 2016 Jul 14.

9.

The isolation and characterization of CTC subsets related to breast cancer dormancy.

Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George GC, Hong DS, Marchetti D.

Sci Rep. 2015 Dec 3;5:17533. doi: 10.1038/srep17533.

10.

Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma.

Hong DS, Kurzrock R, Falchook GS, Andresen C, Kwak J, Ren M, Xu L, George GC, Kim KB, Nguyen LM, O'Brien JP, Nemunaitis J.

Oncotarget. 2015 Dec 15;6(40):43127-34. doi: 10.18632/oncotarget.5756.

11.

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.

Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S, Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett C, Karp D, Kurzrock R, Zinner R, Raghav K, Subbiah V, Hess K, Meric-Bernstam F, Hong DS, Overman MJ.

BMC Cancer. 2015 Oct 16;15:713. doi: 10.1186/s12885-015-1701-3.

12.

A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors.

Henary H, George GC, Wheler J, Naing A, Piha-Paul S, Fu S, Mistry R, Zinner R, Kurzrock R, Hong DS.

Cancer Chemother Pharmacol. 2015 Sep;76(3):597-603. doi: 10.1007/s00280-015-2824-6. Epub 2015 Jul 26.

PMID:
26210681
13.

Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.

Hong DS, Kurzrock R, Wheler JJ, Naing A, Falchook GS, Fu S, Kim KB, Davies MA, Nguyen LM, George GC, Xu L, Shumaker R, Ren M, Mink J, Bedell C, Andresen C, Sachdev P, O'Brien JP, Nemunaitis J.

Clin Cancer Res. 2015 Nov 1;21(21):4801-10. doi: 10.1158/1078-0432.CCR-14-3063. Epub 2015 Jul 13.

14.

Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.

Hong DS, Garrido-Laguna I, Ekmekcioglu S, Falchook GS, Naing A, Wheler JJ, Fu S, Moulder SL, Piha-Paul S, Tsimberidou AM, Wen Y, Culotta KS, Anderes K, Davis DW, Liu W, George GC, Camacho LH, Percy Ivy S, Kurzrock R.

Cancer. 2014 Jul 15;120(14):2164-73. doi: 10.1002/cncr.28701. Epub 2014 Apr 17.

15.

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.

Henary H, Hong DS, Falchook GS, Tsimberidou A, George GC, Wen S, Wheler J, Fu S, Naing A, Piha-Paul S, Janku F, Kim KB, Hwu P, Kurzrock R.

Ann Oncol. 2013 Aug;24(8):2158-65. doi: 10.1093/annonc/mdt115. Epub 2013 Apr 10.

16.

Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapy.

Hong DS, George GC, Iwuanyanwu EC, Tavana B, Falchook GS, Piha-Paul SA, Wheler JJ, Mistry RH, Lei X, Kurzrock R.

J Cancer Res Clin Oncol. 2013 Jun;139(6):963-70. doi: 10.1007/s00432-013-1404-6. Epub 2013 Mar 2.

PMID:
23455881
17.

Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions.

Hong DS, Banerji U, Tavana B, George GC, Aaron J, Kurzrock R.

Cancer Treat Rev. 2013 Jun;39(4):375-87. doi: 10.1016/j.ctrv.2012.10.001. Epub 2012 Nov 28. Review.

PMID:
23199899
18.

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

Hong DS, Choe JH, Naing A, Wheler JJ, Falchook GS, Piha-Paul S, Moulder SL, George GC, Choe JM, Strauss LC, Gallick GE, Kurzrock R.

Invest New Drugs. 2013 Aug;31(4):918-26. doi: 10.1007/s10637-012-9898-3. Epub 2012 Nov 20.

19.

A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors.

Hong DS, Bowles DW, Falchook GS, Messersmith WA, George GC, O'Bryant CL, Vo AC, Klucher K, Herbst RS, Eckhardt SG, Peterson S, Hausman DF, Kurzrock R, Jimeno A.

Clin Cancer Res. 2012 Aug 1;18(15):4173-82. doi: 10.1158/1078-0432.CCR-12-0714. Epub 2012 Jun 12.

20.

Associations among dietary supplement use and dietary and activity behaviors by sex and race/ethnicity in a representative multiethnic sample of 11th-grade students in Texas.

George GC, Springer AE, Forman MR, Hoelscher DM.

J Am Diet Assoc. 2011 Mar;111(3):385-93. doi: 10.1016/j.jada.2010.11.019.

PMID:
21338737
21.

Association between depressed mood and perceived weight in middle and high school age students: Texas 2004-2005.

Schiefelbein EL, Mirchandani GG, George GC, Becker EA, Castrucci BC, Hoelscher DM.

Matern Child Health J. 2012 Jan;16(1):169-76. doi: 10.1007/s10995-010-0733-1.

PMID:
21165762
22.

Diet- and body size-related attitudes and behaviors associated with vitamin supplement use in a representative sample of fourth-grade students in Texas.

George GC, Hoelscher DM, Nicklas TA, Kelder SH.

J Nutr Educ Behav. 2009 Mar-Apr;41(2):95-102. doi: 10.1016/j.jneb.2008.05.006.

23.

Reproducibility of the School-Based Nutrition Monitoring Questionnaire among fourth-grade students in Texas.

Penkilo M, George GC, Hoelscher DM.

J Nutr Educ Behav. 2008 Jan-Feb;40(1):20-7. doi: 10.1016/j.jneb.2007.04.375.

PMID:
18174100
24.

Compliance with dietary guidelines and relationship to psychosocial factors in low-income women in late postpartum.

George GC, Milani TJ, Hanss-Nuss H, Freeland-Graves JH.

J Am Diet Assoc. 2005 Jun;105(6):916-26.

PMID:
15942541
25.

Food choices of low-income women during pregnancy and postpartum.

George GC, Hanss-Nuss H, Milani TJ, Freeland-Graves JH.

J Am Diet Assoc. 2005 Jun;105(6):899-907.

PMID:
15942539
26.

Relative validity and reliability of a food frequency questionnaire for a triethnic population of 1-year-old to 3-year-old children from low-income families.

Klohe DM, Clarke KK, George GC, Milani TJ, Hanss-Nuss H, Freeland-Graves J.

J Am Diet Assoc. 2005 May;105(5):727-34.

PMID:
15883549
27.

Modern psychiatric community services in the RSA.

George GC.

S Afr Med J. 1988 Sep 3;74(5):249-50. No abstract available.

PMID:
3413621
28.

The compulsory treatment of alcoholic drunken drivers referred by the courts: a 7 to 9 years outcome study.

Ben-Arie O, Swartz L, George GC.

Int J Law Psychiatry. 1986;8(2):229-35. No abstract available.

PMID:
3957526
29.

Compulsory treatment of 50 alcoholic drunken drivers. A follow-up study.

Ben-Arie O, George GC, Hirschowitz J.

S Afr Med J. 1983 Feb 12;63(7):241-3.

PMID:
6823641
30.

Thyrotropic hormone and psychiatric symptoms.

Beumont PJ, Glaun D, George GC, Touyz SW.

Biol Psychiatry. 1981 Jul;16(7):671-7. No abstract available.

PMID:
6791710
31.

A case of tranylcypromine ('Parnate') addiction.

Ben-Arie O, George GC.

Br J Psychiatry. 1979 Sep;135:273-4.

PMID:
486854
32.

"Dieters" and "vomiters and purgers" in anorexia nervosa.

Beumont PJ, George GC, Smart DE.

Psychol Med. 1976 Nov;6(4):617-22.

PMID:
1005578
33.

Body weight and the pituitary response to hypothalamic releasing hormones in patients with anorexia nervosa.

Beumont PJ, George GC, Pimstone BL, Vinik AI.

J Clin Endocrinol Metab. 1976 Sep;43(3):487-96.

PMID:
821959
34.

Some personality characteristics of patients with anorexia nervosa.

Smart DE, Beumont PJ, George GC.

Br J Psychiatry. 1976 Jan;128:57-60.

PMID:
1252703
35.

Letter: Scurvy in anorexia nervosa.

George GC, Zabow T, Beumont PJ.

S Afr Med J. 1975 Aug 16;49(35):1420. No abstract available.

PMID:
1166360
36.

Letter: Thyrotrophin-releasing hormone in depression.

Smart D, Beumont PJ, George GC.

Lancet. 1975 Feb 1;1(7901):286. No abstract available.

PMID:
46438
37.

Letter: Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women.

Utian WH, George GC, Beumont PJ, Beardwood CJ.

S Afr Med J. 1974 Jun 1;48(26):1093. No abstract available.

PMID:
4367281
38.

Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women.

George GC, Utian WH, Beaumont PJ, Beardwood CJ.

S Afr Med J. 1973 Dec 15;47(49):2387-8. No abstract available.

PMID:
4358176
39.

Transsexualism in a fourteen-year-old male.

George GC, Beumont PJ.

S Afr Med J. 1972 Dec 9;46(49):1947-8. No abstract available.

PMID:
4653998

Supplemental Content

Loading ...
Support Center